Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma

NCT05659251 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma
Neoadjuvant Therapy

Interventions

COMBINATION_PRODUCT: Serplulimab, Albumin paclitaxel, carboplatin AUC=5, neoadjuvant therapy
PROCEDURE: Esophagectomy
OTHER: sample

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University